Stemedica Asia PTE, LTD, a wholly owned subsidiary of Stemedica Cell Technologies, Inc., a leading manufacturer of adult allogeneic stem cells and stem cell factors, announced that the Company has entered into a definitive licensing agreement with the Stem Cell and Cancer Institute, a division of PT Kalbe Farma .
http://www.prweb.com/releases/stemedica-stem-cells/kalbe-asia-licensing/prweb10613321.htm
http://www.prweb.com/releases/stemedica-stem-cells/kalbe-asia-licensing/prweb10613321.htm
No comments:
Post a Comment